Zimmer Biomet Holdings, Inc.

ZBH · Healthcare · · USD

98.07 USD

0.00 (-0.86%)

● Updated 2026-09-07 20:34 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score BUY Short-term (Swing)

/ 100

Technical 75

Trend & RS 84

Momentum 62

Fundamental (0%) 63

Macro 64

Liquidity 40

Component	Score	Weight
Technical	75.0	40%
Trend & RS	84.2	20%
Momentum	62.0	20%
Fundamental	63.2	0%
Macro	64.4	15%
Liquidity	39.7	5%

Trade Setup

Entry	98.07
Stop Loss	92.69 (5.5%)
Target 1 (1:1)	103.45 (+5.5%)
Target 2 (2:1)	108.83 (+11.0%)

ATR(14)	2.69 (2.7%)
Risk per Share	5.38
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	73.0	+0.92
Momentum	62.0	+0.48
Quality	35.3	-0.59
Composite	56.7

Quality Scores

Piotroski F-Score 6 /9 — Average

✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✗

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score 2.99 — Grey Zone

Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Undervalued

Metric	Stock	Sector	vs Peers
P/E Ratio	23.8	22.0	Inline
P/B Ratio	1.5	4.0	Below
Dividend Yield	98.0%	1.5%	Above avg

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value

57.37

Market Price

98.07

Upside

-41.5%

Margin of Safety	-70.9%
Stage 1 PV (5yr FCF)	2,798,133,403
Terminal Value PV	8,145,320,018
Total Enterprise Value	10,943,453,421

Assumptions

Base FCF	628,671,423
Growth Rate (5yr)	4.8%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

46.28%

Full Kelly

23.14%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 71/100. Estimated win rate 61%, avg win 9.3%, avg loss 3.6%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

50.01

RSI(14)

1.1747

MACD

Relative Strength (RS) IMPROVING

/ 99

RS Rating

O'Neil filter: <80

RS vs SPY	↑ RISING (+7.9% vs SPY 3M)
RS vs Sector	OUTPERFORMING (Healthcare)
RS New High	No (27d since high)
Sector Outperformance	+4.8% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

Indicator	Value	Signal
Rsi	50.01	NEUTRAL
Macd	1.1747	BEARISH
Ma Cross	94.93 / 91.04	GOLDEN CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.78x	NORMAL

Key Levels

Level	Price
52-Week High	106.88
Bollinger Upper	101.97
SMA(200)	91.04
SMA(50)	94.93
SMA(20)	99.5
Current Price	98.07
Bollinger Lower	97.04
52-Week Low	79.12
ATR(14)	2.69

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKUP Confidence

100%

Acc: 0.0 | Dist: 0.0 | Markup: 2.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-08-31	Normal	0.77x	Normal bar — no special VSA pattern
2026-09-01	Normal	0.82x	Normal bar — no special VSA pattern
2026-09-02	Normal	0.82x	Normal bar — no special VSA pattern
2026-09-03	Normal	0.75x	Normal bar — no special VSA pattern
2026-09-04	Normal	0.78x	Normal bar — no special VSA pattern

Ichimoku Cloud NEUTRAL

Line	Value	Status
Tenkan-sen (9)	99.85	Above Kijun
Kijun-sen (26)	96.97	Base line
Senkou A	98.41	Leading span A
Senkou B	93.29	Leading span B
Cloud	93.29 – 98.41	Bullish (Green)
Price vs Cloud	98.07	Inside Cloud
Chikou Span	93.93	Bullish
Alignment Score	3/4	NEUTRAL